Friess Associates LLC Neuronetics, Inc. Transaction History

Friess Associates LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$6.22 - $15.54 $1.81 Million - $4.53 Million	-291,700 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$10.15 - $17.25 $1.49 Million - $2.54 Million	-147,267 Reduced 33.55%	291,700 $4.67 Million
Q1 2021 May 14, 2021	SELL	$10.6 - $21.27 $854,731 - $1.72 Million	-80,635 Reduced 15.52%	438,967 $5.43 Million
Q4 2020 Feb 12, 2021	BUY	$4.95 - $11.45 $2.57 Million - $5.95 Million	519,602 New	519,602 $5.77 Million
Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $575,847 - $1.1 Million	-63,983 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.6 - $19.58 $2.41 Million - $3.47 Million	-177,301 Reduced 73.48%	63,983 $976,000
Q4 2018 Feb 14, 2019	BUY	$16.0 - $31.84 $3.16 Million - $6.3 Million	197,712 Added 453.76%	241,284 $4.67 Million
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $451,671 - $697,192	18,572 Added 74.29%	43,572 $1.4 Million
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $665,250 - $694,500	25,000 New	25,000 $665,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $66.5M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.